Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Softbank Ventures Asia
AddedFeb 13, 2024
UpdatedJun 28, 2026
Softbank Ventures Asia

Softbank Ventures Asia

Acquired

Global venture firm, SoftBank Ventures Korea Corp., specializes in early to growth stage ICT startups.

Location
Seoul, Seoul, KR
Founded
2000
Firm
Compare
Portfolio
Fundraising
Employees
News

Investments

ImpriMed
ImpriMed

Total Raised

$34.7M

Rounds

5

Series A$23MNovember 2023
Syncly
Syncly

Total Raised

$3.5B

Rounds

2

Seed$3.5BMay 2023
Kream
Kream

Total Raised

$410.6B

Rounds

4

Series C$220.6BMarch 2023
Series B$100BOctober 2021
Series A$40BMarch 2021
MarqVision
MarqVision

Total Raised

$25M

Rounds

2

Series A$20MAugust 2022
Aquabyte
Aquabyte

Total Raised

$48.8M

Rounds

5

Series B$25MJuly 2022
Super
Super
Series C

Total Raised

$105M

Rounds

4

Series C$70MJune 2022
Series B$28MApril 2021
June Homes
June Homes

Total Raised

$50M

Rounds

7

Series B$27MSeptember 2021
Series A$13MJanuary 2021
Blueshift Labs
Blueshift Labs

Total Raised

$104.6M

Rounds

6

Series C$30MFebruary 2021
Series B$20MApril 2019
LeaseLock
LeaseLock

Total Raised

$63.5M

Rounds

9

Series B$52MFebruary 2021
Retrace
Retrace

Total Raised

$18M

Rounds

1

Series A$18MMay 2020
Anodot
Anodot

Total Raised

$64.5M

Rounds

7

Series C$35MApril 2020
Bluepoint Partners
Bluepoint Partners

Total Raised

$11B

Rounds

2

Series Unknown$11BFebruary 2020
Mythic
Mythic

Total Raised

$164.7M

Rounds

6

Series B$30MJune 2019
Series B$40MMarch 2018
Blind
Blind

Total Raised

$71.5M

Rounds

8

Series B$15MNovember 2018
Rael
Rael

Total Raised

$55.3M

Rounds

6

Series A$17.5MNovember 2018
Seed$2.8MMay 2018
Iyuno-Sdi
Iyuno-Sdi

Total Raised

$183.5M

Rounds

4

Series A$23.5MApril 2018
Aria Pharmaceuticals
Aria Pharmaceuticals

Total Raised

$14.3M

Rounds

4

Series A$10MMarch 2018
Wonder Workshop
Wonder Workshop

Total Raised

$80.8M

Rounds

7

Series C$41MOctober 2017